Silibinin attenuates methotrexate-induced pulmonary injury by targeting oxidative stress
- PMID: 26622344
- PMCID: PMC4509095
- DOI: 10.3892/etm.2015.2542
Silibinin attenuates methotrexate-induced pulmonary injury by targeting oxidative stress
Abstract
The aim of the present study was to assess the protective effect of silibinin against methotrexate (MTX)-induced pulmonary toxicity. Rats were divided into four groups (MTX, MTX + silibinin, silibinin and control. MTX was injected intraperitoneally (i.p) into female Wistar rats (10 mg/kg/day for 3 days), which resulted in significant increases in the serum levels of alanine aminotransferase, aspartate aminotransferase and oxidant enzymes, including nitric oxide and myeloperoxidase. Furthermore, significant reductions were detected in the serum activity levels of the antioxidative enzymes, glutathione peroxidase and superoxide dismutase, when compared with the control group. However, administration of silibinin (100 mg/kg/day for 10 days, i.p.) was shown to ameliorate the MTX-induced pulmonary toxicity, as indicated by the normalization of the oxidative stress parameters. Furthermore, silibinin treatment was demonstrated to reduce the histopathological changes associated with MTX. In conclusion, silibinin exhibited protective effects against MTX-induced pulmonary toxicity, which may be attributed to its antioxidant activity.
Keywords: antioxidant; methotrexate; pulmonary toxicity; rat; silibinin.
Figures
References
-
- Abelson HT, Fosburg MT, Beardsley GP, Goorin AM, Gorka C, Link M, Link D. Methotrexate-induced renal impairment: Clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine. J Clin Oncol. 1983;1:208–216. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials